Your browser doesn't support javascript.
loading
Plasma adiponectin and serum advanced glycated end-products increase and plasma lipid concentrations decrease with increasing duration of type 2 diabetes.
Gottsäter, A; Szelag, B; Kangro, M; Wroblewski, M; Sundkvist, G.
Affiliation
  • Gottsäter A; Department of Vascular Diseases, Malmo University Hospital, Malmo, Sweden.
Eur J Endocrinol ; 151(3): 361-6, 2004 Sep.
Article in En | MEDLINE | ID: mdl-15362966
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Proteins / Glycation End Products, Advanced / Intercellular Signaling Peptides and Proteins / Diabetes Mellitus, Type 2 / Diabetic Retinopathy / Lipids Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Middle aged Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2004 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Proteins / Glycation End Products, Advanced / Intercellular Signaling Peptides and Proteins / Diabetes Mellitus, Type 2 / Diabetic Retinopathy / Lipids Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Middle aged Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2004 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido